Misuzu Mori

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka et al. · Gastric Cancer · 2017 · 45 citations · Full text

Medicine, Oncology, Pharmacology +15

Inhibitory Effect of Lithium on the Release of Thyroid Hormones from Thyrotropin-Stimulated Mouse Thyroids in a Perifusion System*

Misuzu Mori, Koji Tajima, Yasuo Oda et al. · Endocrinology · 1989 · 40 citations

Medicine, Endocrinology, Pharmacology +11

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Hironaga Satake, Yu Sunakawa, Yuji Miyamoto et al. · Oncotarget · 2018 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

<b>INHIBITORY EFFECT OF NEUROMEDIN B ON THE RELEASE OF THYROTROPIN FROM PERIFUSED RAT </b><b>PITUITARIES </b>

Koji Tajima, Mitsuyoshi Namba, Yasuo Oda et al. · Biomedical Research · 1989 · 13 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Apolipoprotein E-Containing Lipoproteins and LRP1 Protect From NMDA-Induced Excitotoxicity Associated With Reducing α2-Macroglobulin in Müller Glia

Hideki Hayashi, Misuzu Mori, Mina Harashima et al. · Investigative Ophthalmology & Visual Science · 2021 · 13 citations · Full text

Medicine, Neurobiology, Neuroscience +17